Results
1 -
10 of
51
(Click
here to explore results)
- Targeting a cell wall biosynthesis hot spot. Anna Müller, Anna Klöckner, Tanja Schneider
, Nat. Prod. Rep.
, 2017
, 34
, 909
- Application of REDOR
NMR in natural product chemistry. Shigeru Matsuoka, Masayuki Inoue
, Chem. Commun.
, 2009
, 5664
- Inhibitors targeting on cell wall biosynthesis pathway of MRSA. Haihong Hao, Guyue Cheng, Menghong Dai, Qinghua Wu, Zonghui Yuan
, Mol. BioSyst.
, 2012
, 8
, 2828
- Inhibition of d-Ala incorporation into wall teichoic acid in Staphylococcus aureus by desleucyl-oritavancin. J. Chang, L. Coffman, S. J. Kim
, Chem. Commun.
, 2017
, 53
, 5649
- Actinomycetes: still a source of novel antibiotics. Olga Genilloud
, Nat. Prod. Rep.
, 2017
, 34
, 1203
- A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics. Paramita Sarkar, Venkateswarlu Yarlagadda, Chandradhish Ghosh, Jayanta Haldar
, Med. Chem. Commun.
, 2017
, 8
, 516
- The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Bee Ha Gan, Josephine Gaynord, Sam M. Rowe, Tomas Deingruber, David R. Spring
, Chem. Soc. Rev.
, 2021
, 50
, 7820
- Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin. Mu Cheng, Zyta M. Ziora, Karl A. Hansford, Mark A. Blaskovich, Mark S. Butler, Matthew A. Cooper
, Org. Biomol. Chem.
, 2014
, 12
, 2568
- Cyclic peptide drugs approved in the last two decades (2001–2021). Huiya Zhang, Shiyu Chen
, RSC Chem. Biol.
, 2022
, 3
, 18
- Natural product and natural product derived drugs in clinical trials. Mark S. Butler, Avril A. B. Robertson, Matthew A. Cooper
, Nat. Prod. Rep.
, 2014
, 31
, 1612